Carbon nanotubes (CNT) are intensively being developed for biomedical applications including drug and gene delivery. Although all possible clinical applications will require compatibility of CNT with the biological milieu, their in vivo capabilities and limitations have not yet been explored. In this work, water-soluble, singlewalled CNT (SWNT) have been functionalized with the chelating molecule diethylentriaminepentaacetic (DTPA) and labeled with indium ( 111 In) for imaging purposes. Intravenous (i.v.) administration of these functionalized SWNT (f-SWNT) followed by radioactivity tracing using gamma scintigraphy indicated that f-SWNT are not retained in any of the reticuloendothelial system organs (liver or spleen) and are rapidly cleared from systemic blood circulation through the renal excretion route. The observed rapid blood clearance and half-life (3 h) of f-SWNT has major implications for all potential clinical uses of CNT. Moreover, urine excretion studies using both f-SWNT and functionalized multiwalled CNT followed by electron microscopy analysis of urine samples revealed that both types of nanotubes were excreted as intact nanotubes. This work describes the pharmacokinetic parameters of i.v. administered functionalized CNT relevant for various therapeutic and diagnostic applications.
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nanomedicine ͉ blood circulation half-life ͉ drug delivery ͉ pharmacokinetics ͉ nanotoxicology C arbon nanotubes (CNT) represent the structural evolution of the archetypal molecular architecture consisting of pure carbon units, the C 60 fullerene (1) . CNT, or ''buckytubes'' (2, 3) , possess extraordinary properties, including high electrical and thermal conductivity, great strength, and rigidity, and are being developed for a wealth of applications, including field emission (4), energy storage (5) , molecular electronics (6) (7) (8) , and atomic force microscopy (9) . CNT have proven difficult to solubilize in aqueous solutions, limiting their use in biological applications. One of the most commonly used strategies to render CNT soluble in aqueous media, and therefore, potentially useful to biomedical applications, is through their surface functionalization (9, 10) . The biomedical applications of CNT are still in their exploratory stage; however, significant promise has been shown (11) . Such applications include their use as DNA biosensors (12) , protein biosensors (13) and transporters (14) , or ion channel blockers (15) .
We have previously demonstrated that peptide-functionalized CNT are capable of penetrating the mammalian plasma membrane and translocating to the cell nucleus (16) and that these nanotubes are capable of eliciting an antigen-specific neutralizing antibody response in vivo (17) . More recently, we reported the first case of CNT-mediated intracellular delivery of plasmid DNA using ammonium-functionalized single-walled CNT (SWNT-NH 3 ϩ ) leading to gene expression levels up to 10-fold that of naked DNA alone (18) . These observations pave the way for the use of CNT as delivery systems for therapeutic and diagnostic molecules. In view of such biomedical applications of functionalized CNT ( f-CNT), their in vivo behavior needs to be identified. It is imperative to determine two equally important in vivo parameters before any clinical application of CNT can be deemed feasible, namely their toxicological and pharmacological profiles.
Elucidating the in vivo pharmacological profiles of administered CNT is considered very important in the context of the underlying medical debate regarding the safety of novel nanomaterials. The harmful effects of nanotubes, because of their nanoscale dimensions and carbon backbone, may arise from their capability to readily enter the respiratory tract (portal of entry), deposit in the lung tissue, redistribute from their site of deposition, escape from the normal phagocytic defenses, and modify the structure of proteins. In such ways, nanotubes can potentially activate inflammatory and immunological responses, affecting normal organ function. Recently, a number of studies have examined the toxicological profile of CNT and other fullerene-based nanostructures in vivo (19) (20) (21) (22) (23) (24) (25) (26) . Most of the CNT cytotoxicity studies have focused on the pulmonary toxicity after inhalation (20) , intratracheal instillation (22, 23) , and pharyngeal aspiration (24) , as well as their effects on skin toxicity after exposure of skin to CNT (19, 21) , and subcutaneous (s.c.) administration (25, 26) , reporting acute pulmonary toxicity effects, induction of granulomas, and inflammatory reactions to the CNT. However, all of these studies used pristine, nonfunctionalized CNT, usually dispersed in an aqueous buffer with the aid of a surfactant such as Tween 80 (23) .
A very recent report looked at the toxicity profile of acid-treated CNT of two different lengths (220 and 825 nm) s.c. administered to rats and reported no severe inflammatory response such as necrosis, tissue degeneration, or neutrophil infiltration (26) . As has been reported for fullerenes and CNT, functionalization and the ensuing improvements in the aqueous solubility, and, therefore, biocompatibility of these materials, improve dramatically the toxicity profile observed in vitro (27, 28) . Previously we reported that the water-soluble f-CNT used in the present study also exhibited a favorable in vitro toxicity profile (16, 18) . However, no systematic in vivo study has been reported on the toxicological profile of f-CNT.
More importantly, studies on the identification of the pharmacological profile of i.v. administered CNT are lacking completely. Critical pharmacological parameters such as blood circulation and clearance half-life, organ biodistribution, and accumulation that are essential for the development of any pharmaceutical have yet to be determined. This need is of fundamental importance for the development of novel nanomaterial-based delivery systems for therapeutics (29) . In the present work, we are presenting previously unreported data on blood circulation and clearance half-life, as well as tissue biodistribution of two types of radiolabeled functionalized single-walled CNT ( f-SWNT) after i.v. administration.
Results and Discussion
The ammonium-functionalized CNT (single-and multiwalled) prepared following the 1,3-dipolar cycloaddition method were used to covalently link the diethylentriaminepentaacetic (DTPA) dianhydride (30) . This chelating agent allows the complexation of radiometal and͞or lanthanide agents such as 111 In, which is one of the most common radionuclides used in biodistribution studies of therapeutic molecules (31) . The dianhydride form of DTPA readily reacts with CNT 1 (Scheme 1), and the derived DTPA-CNT can be subsequently chelated with 111 In. Two different amounts of DTPA dianhydride were used to (i) completely saturate the amino functions on the CNT (2) and (ii) react only 60% of the amino functions with DTPA (4) . The quantitative Kaiser test was used to establish the amount of free amino functions around the sidewalls of the nanotubes.
f-CNT were examined and characterized by transmission electron microscopy (TEM). Fig. 1 shows images characteristic of f-SWNT and functionalized multiwalled CNT ( f-MWNT) obtained after dispersion of the sample onto a TEM grid and evaporation of the solvent.
The presence of free amino functions on SWNT 4 allowed for evaluation of the effect of nanotube surface charge distribution on in vivo tissue biodistribution compared with the DTPA-saturated SWNT 2. Once the DTPA-CNT derivatives 2 and 4 were isolated and characterized (Table 1) , they were complexed with 111 In. Both types of DTPA-SWNT were incubated in a solution of [
111 In]citrate to generate, upon chelation, a final radioactivity load of 20 Ci (1 Ci ϭ 37 GBq) for 60 g of conjugate, which was the dose of [ 111 In]DTPA-SWNT administered to each animal. As a consequence, one indium isotope was caged in every Ϸ70,000 or Ϸ42,000 DTPA moiety at the surface of nanotubes 3 and 5, respectively. The complexation reaction was extremely efficient, and the chelating agent caged the radionuclide. We verified that CNT did not cause any reduced or incomplete chelation of the indium. For this purpose, we prepared a DTPA derivative by reacting DTPA dianhydride with the amino acid phenylalanine. The derivative could be easily characterized by HPLC alone and complexed to the indium. The efficiency of the DTPA-(Phe-NH 2 ) 2 agent was measured by incubation with different amounts of indium. In particular, the completeness of indium chelation using a ratio of 2:1 DTPA-(Phe-NH 2 ) 2 to indium was evaluated. This ratio is much lower than that used to chelate 111 In on the SWNT (70,000:1 or 42,000:1). Subsequently, DTPA-SWNT were incubated with indium in a 2:1 molar ratio. After 1 h, DTPA-(Phe-NH 2 ) 2 was added, and the solution was analyzed by HPLC. No trace of [In]DTPA-(Phe-NH 2 ) 2 was detected as a consequence of a complete chelation of the indium by the DTPA-SWNT. We also incubated the SWNT 1 devoid of the DTPA group with indium, and after 1 h we added DTPA-(Phe-NH 2 ) 2 to completely recover the [In]DTPA-(Phe-NH 2 ) 2 complex. These experiments indicated that our DTPA-SWNT conjugate is extremely efficient in chelating the radioisotope for the biodistribution studies.
We then compared the tissue distribution and affinity over time after i.v. injection of [ 111 In]DTPA-SWNT 3, which possess no free amino groups, with that of [ 111 In]DTPA-SWNT 5, which possess 40% of free amino groups (Table 1 ) and, therefore, a different surface-charge distribution. Similar to numerous cationic molecules, such as cationic lipids, which are used to condense plasmid DNA for gene delivery and are known to have many interactions with blood proteins which may affect their pharmacokinetics (32, 33) , we hypothesized that evaluation of the effect of charge on nanotube biodistribution is an important parameter toward the development of f-CNT for systemic gene delivery. We were able to detect the presence of both types of the f-SWNT in all of the organs examined 30 min after administration, with the higher levels of radioactivity found in the muscle, skin, kidney, and blood (Tables 2 and 3 ) for both types of nanotubes. Interestingly, although it appears that after 30 min the [
111 In]DTPA-CNT 5 may be found in the kidney, muscle, skin, and lung at slightly higher affinity than [ 111 In]DTPA-CNT 3, in both cases the nanotubes are rapidly cleared from all tissues (Fig. 2) . A closer examination of the tissue affinity data indicates that Ϸ20% of the injected dose of nanotubes can be found per gram of tissue in the kidneys of mice administered [
111 In]DTPA-SWNT 5 after 30 min, with 8.5% in the muscle, 9% in the skin, and 1.3% in the lungs (Table 2) . By comparison, the tissue affinity of [
111 In]DTPA-CNT 3 after 30 min is 10.5% in the kidney, with Ϸ6% in the muscle, 2% in the skin, and Ͻ0.5% found in the lung.
The high levels of 111 In found in the kidney after 30 min and the rapid decline in the overall radioactivity levels thereafter indicate that most of the nanotubes are eliminated through the renal excretion route. A simple calculation from the data presented in Table 3 indicates that after 3 h, Ͻ1% of [
111 In]DTPA-CNT 3 is detectable in all organs measured, falling to Ͻ0.7% after 24 h. A 
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similar rapid decline in percent dose of nanotubes remaining can be observed with the [ 111 In]DTPA-CNT 5 because Ͻ2% of the injected dose remains after 3 h before falling to Ͻ1%. The differences between the two types of tubes are not considered statistically significant.
After this biodistribution study, we carried out an in vivo excretion study to investigate the presence of f-SWNT and f-MWNT in the excreted urine. f-MWNT were included to examine whether i.v. administered CNT of larger dimensions compared with f-SWNT (Fig. 1) were excreted in urine. Doses of 400 g of DTPA-SWNT 4 and DTPA-MWNT 4 were administered i.v., and urine was collected within an 18-h period after administration. All animals exhibited no signs of acute toxicity after administration even at these higher CNT doses. TEM analysis of urine samples indicated the abundant presence of intact f-SWNT and f-MWNT (Fig. 3) . These observations confirmed that both f-SWNT and f-MWNT are cleared from systemic blood circulation through the renal excretion route and into urine as intact nanotubes.
In contrast to Wang et al. (34) , who examined the organ distribution of carboxylated CNT after i.p. administration and observed some accumulation in bone, we did not see any organspecific accumulation of i.v. administered nanotubes over time. None of the animals in our studies exhibited any signs of renal or other severe acute toxicity responses; however, more systematic toxicological studies need to be performed. Radioactive tracer studies similar to ours (35) that determined the biodistribution of functionalized fullerenes (buckyballs), which were far smaller than the nanotubes used here, indicated that these smaller fullerenes had varying affinities for the liver, spleen, bone, and kidney, depending on the functional group. Carboxylic acid functionalized fullerenes exhibiting high levels of retention were observed even 48-72 h after i.v. administration, whereas hydroxyl-functionalized fullerenes were rapidly excreted through urine for both rats and rabbits (35) (36) (37) . More interestingly, it was reported that carboxyl-functionalized fullerenes were able to penetrate the blood-brain barrier, contrary to hydroxyl-functionalized fullerenes, which did not.
Such observations have direct implications for the use of carbonbased nanomaterials as delivery systems and highlight the importance of the type of functionalization on the pharmacokinetic and tissue biodistribution profile obtained. The lack of any organspecific affinity for the nanotubes in the present study can be considered an advantage for the development of targeted nanotubes, because there is no innate tissue affinity to overcome. Importantly, liver accumulation and hepatic toxicity has previously rendered many delivery systems ineffective; however, f-CNT-based delivery systems may offer an alternative because no inherent liver accumulation is observed.
Finally, to further elucidate the pharmacokinetic profile of the functionalized nanotubes, we calculated the blood clearance rates of the two types of radiolabeled f-SWNT (Fig. 4). [
111 In]DTPA-SWNT 5 have a blood circulation half-life of Ϸ3 h, and [
111 In]DT-PA-SWNT 3 have a half-life of just over 3.5 h. To our knowledge, such a calculation has not been made previously for any kind of CNT administered in vivo. Because the cationic f-SWNT have already been demonstrated to be capable of delivering plasmid DNA to cells in vitro (18, 38) , this work is an important step toward the development of such nanotubes for systemic gene transfer.
To put these rates in context with other commonly used gene therapy vectors, Ͻ10% of i.v. injected adenovirus can be found in the blood as little as 10 min after i.v. injection, falling to Ͻ1% after 1 h, representing a blood clearance half-life of only 2 min (39). Cationic lipoplexes are cleared even more rapidly, with only 10% of the injected dose of some formulations remaining detectable in the blood as little as 1 min after i.v. injection (40) . Polyplexes formed Conversely, the blood circulation half-life of the f-CNT in this study is significantly shorter than that of other functionalized C 60 fullerenes, which have been shown to have a blood half-life of 6.8 h after i.v. administration (43) . These fullerenes do not appear to be excreted through the urine and seem to have a high level of affinity for plasma proteins. Perhaps the short blood half-life of the i.v. injected nanotubes in the present study is an indication of low interaction with blood proteins.
Conclusions
We observed that surface charge density differences of functionalized, water-soluble, and 111 In-labeled DTPA-SWNT do not alter their tissue selectivity, because both types studied followed a rapid, first-order clearance from the blood compartment through the renal excretion route without any toxic side effects or mortality. Furthermore, we were able to visualize intact f-SWNT and f-MWNT in excreted urine. These observations are important as a further indication that functionalized, and thereby water-soluble and biocompatible, carbon nanomaterial exhibit a significantly improved toxicity profile compared with their nonfunctionalized counterparts. The [ 111 In]DTPA-SWNT 5, carrying free ammonium groups included in this study, also can be used to complex and deliver nucleic acids across mammalian cell surfaces, offering the possibility for systemic gene transfer. This work presents previously undescribed pharmacokinetic data after i.v. administration of CNT, exhibiting a blood circulation half-life of up to 3.5 h. It is hoped that this work can act as an impetus for further pharmacological investigations of different types of nanotubes to determine the limitations and opportunities CNT-based delivery systems offer.
Materials and Methods
SWNT were purchased from Carbon Nanotechnologies Inc. (Houston). Pristine SWNT used in this experiment were CNI Grade͞Lot No. R0496. According to the manufacturer, the mean diameter of SWNT is Ϸ1 nm. Tubes have lengths between 300 and 1,000 nm. However, the more accurate SWNT length determination after functionalization is a topic of intensive current research because the dispersed tubes organize themselves into ropes. MWNT were purchased from Nanostructured & Amorphous Materials Inc. (Houston). MWNT used in this study were 94% pure (stock no. 1240XH). Their outer diameter was between 20 and 30 nm, and length was between 0.5 and 2 m. The dimensions and structure of the CNT obtained after functionalization used in this study are shown in Fig. 1 . DTPA was selected as the chelating agent, because it has been widely used to chelate different types of radioelements, currently used in radiology clinics. It is commercially available (Aldrich), highly water-soluble, and allows for a simple conjugation chemistry through linkage to the amino functions at the CNT surface. Also, DTPA rapidly cages indium with a highly thermodynamic equilibrium constant (44 Fmoc-Phe-OH (5 equiv) in DMF (6 ml) was added in the presence of Bop͞HOBt͞diisopropylethylamine (DIEA) (5͞5͞15 equiv). The coupling was repeated twice for 20 min. After washings, Fmoc was removed by using a solution of 25% piperidine in DMF. DTPA dianhydride (228 mg; 3 equiv) was added in DMF (5 ml 111 In activity. At 30 min, 3 h, and 24 h after injection, three mice per group were killed, blood was collected, and then the animal was flushed with 10 ml of normal saline via the heart to clear any blood remaining in other organs. Muscle (left thigh), bone (left femur with marrow), skin, heart, lung, liver, kidney, and spleen were collected and placed into preweighed scintillation vials. Each organ was then weighed, and samples were analyzed for 111 In activity using a PerkinElmer (Packard) Cobra II gamma counter. Chelation of 111 In with DTPA and other chelating agents form very stable complexes that are commonly used for in vivo biodistribution studies of various therapeutic molecules and their delivery systems (45) (46) (47) . The stability constant between DTPA and 111 In has been determined by others to be 1.5 ϫ 10 29 (48) , and previous studies have shown that the [
111 In]-DTPA ligand has a strong chelating effect on the radiometal in human serum (44) . Moreover, we characterized the In-DTPA complex using nonradioactive indium by HPLC without any loss of indium, concluding that the chelate is stable under physiological conditions. Excretion Studies and Urine Microscopic Analysis. Female, 8-week-old BALB͞c mice were purchased from Harlan Olac (Bichester, U.K.). Studies were conducted with prior approval from the UK Home Office. Mice were injected via the tail vein with 200 l of PBS containing 400 g of DTPA-SWNT 4. For comparison, separate groups of mice were injected with 200 l of PBS containing 400 g of DTPA-MWNT 4. As a control, four mice were injected with 200 l of PBS alone. Groups of four mice were placed in metabolic cages (Tecniplast UK, Kettering Northants, U.K.), and urine was collected over 18 h. After collection of urine, a sample of 100 l from each group was lyophilized. The pellet obtained was dispersed in methanol or water (2 mg͞ml) and centrifuged (15,000 rpm on a Biofuge 13, Heraeus). The precipitate after centrifugation was resuspended in 100 l of water. Both supernatant and precipitates from each urine sample were analyzed microscopically using TEM.
